These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 26725028)

  • 21. Effects of protease activated receptor (PAR)2 blocking peptide on endothelin-1 levels in kidney tissues in endotoxemic rat mode.
    Jesmin S; Shimojo N; Yamaguchi N; Mowa CN; Oki M; Zaedi S; Sultana SN; Rahman A; Islam M; Sawamura A; Gando S; Kawano S; Miyauchi T; Mizutani T
    Life Sci; 2014 May; 102(2):127-33. PubMed ID: 24641950
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Thromboxane A2 receptor-mediated release of matrix metalloproteinase-1 (MMP-1) induces expression of monocyte chemoattractant protein-1 (MCP-1) by activation of protease-activated receptor 2 (PAR2) in A549 human lung adenocarcinoma cells.
    Li X; Tai HH
    Mol Carcinog; 2014 Aug; 53(8):659-66. PubMed ID: 23475608
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Proteinase-activated receptor-1 (PAR1) and PAR2 mediate relaxation of guinea pig internal anal sphincter.
    Huang SC
    Regul Pept; 2014 Feb; 189():46-50. PubMed ID: 24631471
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterization of Protease-Activated Receptor (PAR) ligands: Parmodulins are reversible allosteric inhibitors of PAR1-driven calcium mobilization in endothelial cells.
    Gandhi DM; Majewski MW; Rosas R; Kentala K; Foster TJ; Greve E; Dockendorff C
    Bioorg Med Chem; 2018 May; 26(9):2514-2529. PubMed ID: 29685684
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Discovery of Protease-activated receptor 2 antagonists derived from phenylalanine for the treatment of breast cancer.
    Kim T; Lee Y; Lim H; Kim Y; Cho H; Namkung W; Han G
    Bioorg Chem; 2024 Sep; 150():107496. PubMed ID: 38850590
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Protease-activated receptors (PAR1 and PAR2) contribute to tumor cell motility and metastasis.
    Shi X; Gangadharan B; Brass LF; Ruf W; Mueller BM
    Mol Cancer Res; 2004 Jul; 2(7):395-402. PubMed ID: 15280447
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fully human antibodies against the Protease-Activated Receptor-2 (PAR-2) with anti-inflammatory activity.
    Giblin P; Boxhammer R; Desai S; Kroe-Barrett R; Hansen G; Ksiazek J; Panzenbeck M; Ralph K; Schwartz R; Zimmitti C; Pracht C; Miller S; Magram J; Litzenburger T
    Hum Antibodies; 2011; 20(3-4):83-94. PubMed ID: 22129678
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diet-induced obesity, adipose inflammation, and metabolic dysfunction correlating with PAR2 expression are attenuated by PAR2 antagonism.
    Lim J; Iyer A; Liu L; Suen JY; Lohman RJ; Seow V; Yau MK; Brown L; Fairlie DP
    FASEB J; 2013 Dec; 27(12):4757-67. PubMed ID: 23964081
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The differential expression of protease activated receptors contributes to functional differences between dark and fair keratinocytes.
    Xue M; Lin H; Zhao R; Liang HP; Jackson C
    J Dermatol Sci; 2017 Mar; 85(3):178-185. PubMed ID: 27979585
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prostate-specific kallikreins-2 and -4 enhance the proliferation of DU-145 prostate cancer cells through protease-activated receptors-1 and -2.
    Mize GJ; Wang W; Takayama TK
    Mol Cancer Res; 2008 Jun; 6(6):1043-51. PubMed ID: 18567807
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Activity of protease-activated receptors in the human submucous plexus.
    Mueller K; Michel K; Krueger D; Demir IE; Ceyhan GO; Zeller F; Kreis ME; Schemann M
    Gastroenterology; 2011 Dec; 141(6):2088-2097.e1. PubMed ID: 21875497
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genetic targeting of protease activated receptor 2 reduces inflammatory astrogliosis and improves recovery of function after spinal cord injury.
    Radulovic M; Yoon H; Wu J; Mustafa K; Fehlings MG; Scarisbrick IA
    Neurobiol Dis; 2015 Nov; 83():75-89. PubMed ID: 26316358
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Proteinase-activated receptors: structural requirements for activity, receptor cross-reactivity, and receptor selectivity of receptor-activating peptides.
    Hollenberg MD; Saifeddine M; al-Ani B; Kawabata A
    Can J Physiol Pharmacol; 1997 Jul; 75(7):832-41. PubMed ID: 9315351
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Protease-activated receptor-2 is essential for factor VIIa and Xa-induced signaling, migration, and invasion of breast cancer cells.
    Morris DR; Ding Y; Ricks TK; Gullapalli A; Wolfe BL; Trejo J
    Cancer Res; 2006 Jan; 66(1):307-14. PubMed ID: 16397244
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of proteinase-activated receptors 1 and 2 in nonsteroidal anti-inflammatory drug enteropathy.
    Fornai M; Colucci R; Pellegrini C; Benvenuti L; Natale G; Ryskalin L; Blandizzi C; Antonioli L
    Pharmacol Rep; 2020 Oct; 72(5):1347-1357. PubMed ID: 32583327
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Therapeutic promise of proteinase-activated receptor-2 antagonism in joint inflammation.
    Kelso EB; Lockhart JC; Hembrough T; Dunning L; Plevin R; Hollenberg MD; Sommerhoff CP; McLean JS; Ferrell WR
    J Pharmacol Exp Ther; 2006 Mar; 316(3):1017-24. PubMed ID: 16260582
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Biomolecular evidence of anti-inflammatory effects by Clematis mandshurica Ruprecht root extract in rodent cells.
    Lee CW; Park SM; Kim YS; Jegal KH; Lee JR; Cho IJ; Ku SK; Lee JY; Ahn YT; Son Y; Ju SA; Kim SC; An WG
    J Ethnopharmacol; 2014 Sep; 155(2):1141-55. PubMed ID: 24975194
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Binding of a highly potent protease-activated receptor-2 (PAR2) activating peptide, [3H]2-furoyl-LIGRL-NH2, to human PAR2.
    Kanke T; Ishiwata H; Kabeya M; Saka M; Doi T; Hattori Y; Kawabata A; Plevin R
    Br J Pharmacol; 2005 May; 145(2):255-63. PubMed ID: 15765104
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Profiling gene expression induced by protease-activated receptor 2 (PAR2) activation in human kidney cells.
    Suen JY; Gardiner B; Grimmond S; Fairlie DP
    PLoS One; 2010 Nov; 5(11):e13809. PubMed ID: 21072196
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Helicobacter pylori activates gastric epithelial cells to produce interleukin-8 via protease-activated receptor 2.
    Kajikawa H; Yoshida N; Katada K; Hirayama F; Handa O; Kokura S; Naito Y; Yoshikawa T
    Digestion; 2007; 76(3-4):248-55. PubMed ID: 18196899
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.